Summit Trail Advisors, LLC Eli Lilly & CO Transaction History

Summit Trail Advisors, LLC

$3.97 Billion
Q3 2024

A detailed history of Summit Trail Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Summit Trail Advisors, LLC holds 7,549 shares of LLY stock, worth $6.01 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

7,549

Previous 6,831 10.51%

Holding current value

$6.01 Million

Previous $6.18 Million 8.13%

% of portfolio

0.17%

Previous 0.16%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$772.14 - $960.02 $554,396 - $689,294	718 Added 10.51%	7,549 $6.69 Million
Q2 2024 Aug 13, 2024	SELL	$724.87 - $909.04 $563,223 - $706,324	-777 Reduced 10.21%	6,831 $6.18 Million
Q1 2024 Apr 23, 2024	BUY	$592.2 - $792.28 $381,376 - $510,228	644 Added 9.25%	7,608 $5.92 Million
Q4 2023 Feb 06, 2024	SELL	$525.19 - $619.13 $45,691 - $53,864	-87 Reduced 1.23%	6,964 $4.06 Million
Q3 2023 Oct 30, 2023	BUY	$434.7 - $599.3 $180,835 - $249,308	416 Added 6.27%	7,051 $3.79 Million
Q2 2023 Jul 25, 2023	BUY	$350.74 - $468.98 $1.24 Million - $1.66 Million	3,531 Added 113.76%	6,635 $3.11 Million
Q1 2023 May 04, 2023	BUY	$310.63 - $364.82 $196,939 - $231,295	634 Added 25.67%	3,104 $1.07 Million
Q4 2022 Feb 07, 2023	BUY	$321.55 - $374.67 $63,023 - $73,435	196 Added 8.62%	2,470 $903,000
Q3 2022 Nov 09, 2022	BUY	$296.48 - $337.87 $193,601 - $220,629	653 Added 40.28%	2,274 $735,000
Q2 2022 Aug 09, 2022	BUY	$278.73 - $327.27 $174,763 - $205,198	627 Added 63.08%	1,621 $526,000
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $234 - $291	1 Added 0.1%	994 $285,000
Q4 2021 Feb 11, 2022	BUY	$224.85 - $279.04 $223,276 - $277,086	993 New	993 $274,000
Q2 2018 Aug 10, 2018	SELL	$75.7 - $86.88 $224,601 - $257,772	-2,967 Closed	0 $0
Q1 2018 May 22, 2018	SELL	$74.21 - $87.6 $17.4 Million - $20.5 Million	-234,266 Reduced 98.75%	2,967 $237,000
Q1 2018 May 21, 2018	BUY	$74.21 - $87.6 $17.4 Million - $20.5 Million	233,930 Added 7082.35%	237,233 $237,000
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $270,647 - $290,300	3,303	3,303 $279,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Trail Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Trail Advisors, LLC with notifications on news.

Account

Summit Trail Advisors, LLC Eli Lilly & CO Transaction History